#Teaching has always been one of my favorite #PhD -related activities at Université de Lausanne! The pleasure is all mine! Thanks for #recognition! #science #research #education #university #students

We're hiring a Senior Genomic Biomarker Scientist to join our growing team in Lausanne. Send your CV and cover letter to [email protected]. Please specify the position you are applying for. To learn more about open positions at HAYA, visit hayatx.com/join-us

Our #DNA can be influenced by many things including our environnement. Through non-coding sequences and #epigenetics many processes are regulated to make us who we are. A lot of things still needs to be decipher in the DNA "#DarkMatter" but our scientists are working on it!

Today is #WorldHealthDay! HAYA is working tirelessly to elucidate the DARK MATTER of the human genome and create SAFE, EFFECTIVE, and ACCESSIBLE therapeutics for a #HealthierTomorrow!

#ICYMI: Marco Mina, HAYA's Director of Computational Biology, spoke about multidisciplinary skills and risky opportunities at the recent Faces of Industrial Research Symposium. Watch his presentation now: youtu.be/qUBZgKDmwhc #compbio #RNA

Great trajectory for Europe! Excited about Apollo's Apollo Health Ventures backing of Haya HAYA Therapeutics as one of the top seed rounds. lnkd.in/eE4hDbwx

Are you a scientist or bioinformatician? Are you passionate about precision therapeutics? If so, come join our R&D teams. We're shedding light on the DARK MATTER of the human genome! Explore opportunities in #Lausanne & #SanDiego: hayatx.com/join-us #sciencejobs #hiring

Samir Ounzain (Samir Ounzain), HAYA's CEO & Scientific Co-Founder, will participate in two panels at Swiss Biotech Day! Join him at Congress Center in Basel, Switzerland on May 2 & 3. Not yet registered? Register here: swissbiotechday.ch/registration/ #SwissBiotechDay SwissBiotech

Attending #SwissBiotechDay today? Don't miss our CEO Samir Ounzain's (Samir Ounzain) talk in the "Emerging Biotech Companies" session at 16:45–17:00 in Room Singapore! swissbiotechday.ch SwissBiotech

Don't miss our CEO Samir Ounzain (Samir Ounzain) at the #SwissBiotechDay panel discussion on "RNA Drugs: Applications Beyond Vaccines" at 15:30–16:15 in Room Osaka/Samarkand! For more information: swissbiotechday.ch SwissBiotech

We're excited to announce that Innosuisse is supporting two research collaboration projects between HAYA and Universität Bern, University Hospital of Bern (Insel Gruppe), and CHUV / Centre hospitalier universitaire vaudois exploring #lncRNA therapies for #cardiac and #oncology applications: bit.ly/3w0VPZH

🇨🇭 Thank you to SwissBiotech for hosting an amazing #SwissBiotechDay this week! We were excited to present our latest #lncRNA research and thoughts on the future applications of RNA drugs alongside Jonathan Hall, Klaas Zuideveld, and Dominik Theler. ETH Zürich Universität Bern Versameb

At HAYA, we're always looking for new talent! Our Project Manager Dmitry (Mityai) Kopelyanskiy enjoyed talking to EPFL, Université de Lausanne, and Université de Genève graduates at Life Science Career Day (LSCD). Thank you to host Life Science Career Day. We're looking forward to seeing many of you again in the near future!

Happy to see our new study published in @FrontCellInfect where we provide novel #insights on the incredible tripartite interaction between a #macrophage, #leishmania #parasite and it's #RNA #virus. frontiersin.org/articles/10.33…

Amazing event and fantastic achievement by the team! Honoured to be part of it!

We’re a young & dynamic team of scientists driven by the desire to effect real change & transform genomic medicine! Inspired by the power of the #darkgenome, we’re on a mission to develop next-generation therapeutics that are SAFE, EFFECTIVE & ACCESSIBLE! youtu.be/nNxNMH7BMB4

From CEO Samir Ounzain’s (Samir Ounzain bottom photo, middle) panel participation to a pitch from our Business & Corporate Development Project Manager Dmitry Kopelyanskiy (Dmitry (Mityai) Kopelyanskiy top photo), the HAYA team had an amazing time at #BIO2023! Thanks Biotechnology Innovation Organization & fellow panelists.

The transition from academia to industry isn’t just possible … it’s fulfilling! Learn how Business & Corporate Development Project Manager Dmitry Kopelyanskiy (Dmitry (Mityai) Kopelyanskiy) made the transition, the challenges faced & the lessons learned along the way. biopole.ch/story/taking-t…

It was a real pleasure to chat about #sciencecommunication, importance of #softskills and my personal journey from Sechenov Moscow Medical Academy, Hebrew University, Rheinische Friedrich-Wilhelms-Universität Bonn and Université de Lausanne to working on #biotech #business & #Corporate development at HAYA Therapeutics! Thanks Dr. What Now? Podcast !

🎙️ It was GREAT to lead my workshop on #scicomm and #presentation #skills for biology and medicine #phd students from the Uni Fribourg at the FGLM UniFR Graduate School's annual retreat! 🧬🔬 Are you Interested in #scicomm and #publicspeaking ? - Let's connect! 🌐